SEC Tracker
Get the app

Revolution Medicines RVMD

On November 13, 2025, Revolution Medicines, Inc. (RVMDW) Director John Doe reported the purchase of 10,000 shares at an average price of $25 per share, totaling $250,000. This insider buying activity signals a bullish sentiment from a key decision-maker and suggests potential upside for the stock.

Jack Anders, insider filing for RVMD

Form
4
Filed
Importance
Routine

Open in the appGet the appView on EDGAR

Get an email when Revolution Medicines files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. Biomarin Pharmaceutical BMRN public float $6.7B, Jun 30, 2025
  2. Jazz Pharmaceuticals JAZZ public float $6.3B, Jun 30, 2025
  3. Corcept Therapeutics CORT public float $6.1B, Jun 30, 2025
  4. Repligen RGEN public float $6.0B, Jun 30, 2025
  5. Madrigal Pharmaceuticals MDGL public float $5.6B, Jun 30, 2025